Larimar Therapeutics Inc
(LRMR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Operating Expenses | 23,214 | 61,122 | 52,999 | 58,225 | 73,813 |
| Operating Income | -23,214 | -61,122 | -52,999 | -58,225 | -73,813 |
| Interest Expense | 0 | 1,898 | 165 | 529 | 806 |
| Other Income | 82 | 1,652 | 1,136 | 876 | 333 |
| Pre-tax Income | -23,132 | -61,368 | -52,028 | -57,878 | -74,286 |
| Net Income Continuous | -23,132 | -61,368 | -52,028 | -57,878 | -74,286 |
| Net Income | $-23,132 | $-61,368 | $-52,028 | $-57,878 | $-74,286 |
| EPS Basic Total Ops | -3.80 | -22.81 | -22.81 | -25.45 | -33.37 |
| EPS Basic Continuous Ops | -3.80 | -22.86 | -22.77 | -25.45 | -33.33 |
| EPS Diluted Total Ops | -3.80 | -22.81 | -22.81 | -25.45 | -33.37 |
| EPS Diluted Continuous Ops | -3.80 | -22.86 | -22.77 | -25.45 | -33.33 |
| EPS Diluted Before Non-Recurring Items | -12.85 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-23,136 | $-61,531 | $-52,565 | $-56,976 | $-72,500 |